LRRK2 and pancreatic neoplasm: To assess the functional effects of LRRK2-IN-1 in vitro we chose to focus on the AsPC-1 human pancreatic cancer and HCT116 human colon cancer cell lines, which are both well characterized for their DCLK1 expression in the literature[7,9,14,15,20-22].